Navigation Links
Press statement on new CDC MRSA study from SHEA president
Date:2/17/2009

A new study from the Centers for Disease Control and Prevention (CDC) shows a decrease in catheter-associated bloodstream infections caused by both methicillin-resistant and methicillin-sensitive S. aureus. The 10-year national study, 'Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997,' reported data from both the National Nosocomial Infection Surveillance (NNIS) and its successor, the National Healthcare Safety Network (NHSN). The study demonstrates a steady decline in intensive care unit catheter-associated MRSA bloodstream infections since 2001.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"Despite the fact that MRSA prevalence continues to rise, efforts to prevent catheter infections are paying dividends and the number of infections due to all types of Staphylococcus aureus, including MRSA, have been falling sharply since 2001. Therefore, simply examining the percentage of staphylococcal isolates that are MRSA can be a misleading indicator of the burden of disease caused by this organism."

"The rate of these infections is decreasing and hospitals are becoming safer for patients because hospitals are instituting and adhering to general practices that result in fewer infections, including measures to ensure proper catheter insertion and removal, hand hygiene, environmental cleanliness, and antimicrobial stewardship.

"Because MRSA only causes about 8% of healthcare-associated infections, it is critical that we not concentrate all of our preventive efforts on a single bacterium. Undue emphasis on a single organism like MRSA can dilute broader-based measures that can have a dramatic effect on infections caused by many different organisms.

"This study illustrates that it is more important for hospitals to focus on the infections and diseases that the germs cause rather than the germs themselves. Decreasing the infections will decrease the burden of disease caused by all resistant organisms and not just MRSA."


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Related biology news :

1. Molecule that suppresses immune response under study in type 1 diabetes
2. UNC study: Tinkering with the circadian clock can suppress cancer growth
3. Pregnancy hormone predicts postpartum depression
4. American Chemical Societys Weekly PressPac -- Jan. 28, 2009
5. DNA component can stimulate and suppress the immune response
6. Cutting salt isnt the only way to reduce blood pressure
7. American Chemical Societys weekly PressPac -- Jan. 14, 2009
8. American Chemical Societys Weekly PressPac -- Jan. 7, 2009
9. Facial expressions of emotion are innate, not learned, says new study
10. Krumlauf Lab demonstrates modulation of gene expression by protein coding regions
11. American Chemical Societys Weekly PressPac -- Dec. 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
Breaking Biology Technology: